Recall events
/
Event 91451
Event summary
Timeline bucket January 13, 2023
Product types Drug
Classifications Class II
Statuses Terminated
Recalling firm wording Nephron Sc Inc
Dossier provenance
Source snapshots represented here
openFDA Drug Enforcement
Report-date coverage
June 20, 2012–July 08, 2026
Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.
Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.
How coverage and grouping work
Device root-cause evidence is not applicable to this event.
No grouped product has the official product type device; this is not an unavailable-enrichment finding.
Complete imported group
Every recalled product in this event
2 official enforcement rows
Product dates, classifications, firms, and source wording remain attached to their individual rows.
Opening this dossier never hides products that did not match a prior timeline filter.
drug · product 1 of 2
Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4
D-0175-2023
Recall number D-0175-2023
Initiated January 13, 2023
Classification Class II
Status Terminated
Quantity 387,000 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Short Fill
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Short Fill
Code information Lot #: 126451 Exp. 04/30/2023
Distribution pattern Nationwide within the United States including Puerto Rico. Guatamala
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[17233]
FDA event record
· Exact recall-number query on openFDA
drug · product 2 of 2
S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL Sterile Unit-of-Use Vials each in a foil pouch, Manufactured By: Nephron West Columbia, SC 29172, NDC 0487-5901-99 UPC 3 04875 90199 9
D-0176-2023
Recall number D-0176-2023
Initiated January 13, 2023
Classification Class II
Status Terminated
Quantity 925,920 vials
App-derived interpretation
Unknown
reason.no_named_rule · v1.0.0
Short Fill
These labels are deterministic app interpretations, not FDA categories.
Inspect official wording and provenance
Reason for recall Short Fill
Code information Lot #: 126461, 126431 Exp. 04/30/2023
Distribution pattern Nationwide within the United States including Puerto Rico. Guatamala
Official fact provenance
Dataset openFDA Drug Enforcement
Snapshot published July 16, 2026 07:03
Snapshot SHA-256 b791303a96cde04f35218bb062dc99bbd2aaedb7873ee857564b5dbe373c2651
Raw source locator 0001-drug-enforcement-0001-of-0001.json.zip#results[16310]
FDA event record
· Exact recall-number query on openFDA